December Issue
Issue:
December 2010
Research funded by the National Institute of Mental Health confirms that S-adenosylmethinone or SAMe exerts potent antidepressant effects when combined with SSRIs. The results of this compelling new human study are detailed, along with SAMe’s ability to protect against degenerative diseases of the brain, liver, and joints.